ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 966 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,351,238 | -38.7% | 34,720 | -35.2% | 0.03% | -34.0% |
Q2 2023 | $3,834,434 | +36.1% | 53,576 | +32.0% | 0.05% | +22.0% |
Q1 2023 | $2,816,658 | +1.4% | 40,580 | -1.0% | 0.04% | 0.0% |
Q4 2022 | $2,777,766 | +25.0% | 40,970 | +1.1% | 0.04% | +36.7% |
Q3 2022 | $2,223,000 | -39.3% | 40,530 | -26.9% | 0.03% | -38.8% |
Q2 2022 | $3,662,000 | +15.1% | 55,430 | +15.6% | 0.05% | +44.1% |
Q1 2022 | $3,181,000 | +95.3% | 47,950 | +71.5% | 0.03% | +277.8% |
Q4 2021 | $1,629,000 | +24.8% | 27,960 | +28.7% | 0.01% | +28.6% |
Q3 2021 | $1,305,000 | +173.0% | 21,730 | +172.3% | 0.01% | +133.3% |
Q2 2021 | $478,000 | +2.1% | 7,980 | -15.2% | 0.00% | 0.0% |
Q1 2021 | $468,000 | -2.9% | 9,410 | -2.5% | 0.00% | 0.0% |
Q4 2020 | $482,000 | -57.0% | 9,650 | -67.3% | 0.00% | -78.6% |
Q4 2018 | $1,120,000 | -31.8% | 29,490 | -29.0% | 0.01% | -26.3% |
Q3 2018 | $1,643,000 | +1.9% | 41,530 | -9.6% | 0.02% | 0.0% |
Q2 2018 | $1,613,000 | – | 45,950 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |